Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Stem Cell Transplant Complications: early-phase trial registry
7 of 16 indexed Stem Cell Transplant Complications trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 7 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Stem Cell Transplant Complications: 16 US clinical trials tracked, 7 recruiting.
Stem Cell Transplant Complications is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Dana-Farber Cancer Institute, running 3 of these trials.
Enrollment posture brief
Registry condition stem-cell-transplant-complications
OPEN 7 | RECR 44% | LATE 2 | EARLY 4 | RANK #1060 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Distress Syndrome (44% recruiting · 32 trials)
Stem Cell Transplant Complications lists 7 open slots (44% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Stem Cell Transplant Complications on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Stem Cell Transplant Complications is recruiting below its size-band peers.
7 of 16 indexed trials (43.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Stem Cell Transplant Complications research.
Dana-Farber Cancer Institute accounts for 3 of 16 trials (18.8%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Stem Cell Transplant Complications enrolment sits around 80 participants.
Median target enrolment is 80 among the 16 trials that report a genuine target (sentinel values excluded). 9 of those (56.3%) plan for fewer than 100 participants.
-
Stem Cell Transplant Complications research is mostly interventional.
12 interventional and 4 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
Massachusetts General Hospital
NCT06541002
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Henry Ford Health System
NCT04623424
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Pierre Fabre Medicament
NCT04554914
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Pierre Fabre Medicament
NCT03394365
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Dana-Farber Cancer Institute
NCT05706766
IS-free Treg HaploHCT
Dana-Farber Cancer Institute
NCT04678401
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
Dana-Farber Cancer Institute
NCT06468618
Delirium in Children Undergoing Stem Cell Transplantation
Weill Medical College of Cornell University
NCT04937400
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
Children's Mercy Hospital Kansas City
NCT03865589
Multidisciplinary Intervention In Chronic GVHD
Massachusetts General Hospital
NCT04479995
Horizons Chronic Graft-Versus-Host-Disease Study
University of Miami
NCT06160986
Ciprofloxacin Versus Levofloxacin in Stem Cell Transplant
Henry Ford Health System
NCT03850379
Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant
Wake Forest University Health Sciences
NCT03355235
A Double-blind Randomized Placebo Controlled Clinical Trial Evaluating Effect of Chlorhexidine Gluconate 2% Cloth vs Placebo Cloth Baths on the Incidence of Central Line-Associated Blood Stream Infections in Outpatient Hematopoietic Stem Cell Transplant Patients
University of Chicago
NCT03030989
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Phoenix Children's Hospital
NCT03176849
Psychological Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation (HCT)
Massachusetts General Hospital
NCT03042715
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Stem Cell Transplant Complications records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Stem Cell Transplant Complications trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Stem Cell Transplant Complications page
16 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Stem Cell Transplant Complications trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dana-Farber Cancer Institute sponsors the most Stem Cell Transplant Complications trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stem Cell Transplant Complications condition card totals 16 registered trials; most-linked intervention Placebo Wipe; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.